We found 3 drugmaker programs for Systemic Juvenile Idiopathic Arthritis medicines and 1 charity fund (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Systemic Juvenile Idiopathic Arthritis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Eligible commercially insured patients may pay as little as $0 per treatment; up to $15,000 per calendar year for drug costs.
Genentech Patient Foundation gives free ACTEMRA to eligible patients, e.g. uninsured or not covered with household income under $150,000 (more for households over 4).
Case Managers explain insurance coverage, find financial help, help with copay program enrollment and coordinate with your doctor and pharmacy.
Copay program excludes Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD and TRICARE. Patients under 18 need a caregiver or legal representative to manage copay help. The free-drug program is run by the separate Genentech Patient Foundation. Case Manager line: 1-800-ACTEMRA (1-800-228-3672), 6AM-5PM PT, Mon-Fri.
Benefits investigation, prior authorization and appeal support, specialty pharmacy coordination, and help finding financial assistance.
Gamifant Copay Assistance Program exists; eligibility checked through Gamifant Cares. Terms not stated on the page.
Gamifant Patient Assistance Program exists; eligibility checked through Gamifant Cares. Criteria not stated on the page.
Official pages name the copay and patient assistance programs but do not say who qualifies or dollar amounts. Call Gamifant Cares for details.
Eligible commercially insured patients pay no more than $30 per month, subject to an annual cap. Federal or state program patients not eligible.
Benefits checks, prior authorization and appeals help, identifying support for uninsured and underinsured patients, delivery coordination, and home nurse injections.
Free Trial Offer: one starter dose of Ilaris at no cost for new patients with urgent medical need, regardless of insurance. One-time use.
Novartis Patient Assistance Foundation provides Ilaris free to eligible patients who are uninsured or have government insurance and meet income limits.
Free drug is through the separate Novartis Patient Assistance Foundation (1-800-277-2254); income limits apply. Program hours Mon-Fri 9 AM-6 PM ET.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 3 drugmaker programs for Systemic Juvenile Idiopathic Arthritis medicines and 1 charity fund, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Systemic Juvenile Idiopathic Arthritis, 0 charity funds on this page accept Medicare, and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 1 fund listed for Systemic Juvenile Idiopathic Arthritis was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Systemic Juvenile Idiopathic Arthritis medicines, 2 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
